Biochemistry Of The Neurotoxic Action Of MPTP And What It May Teach Us About The Etiology Of Idiopathic Parkinsonism
- 93 Downloads
The past four years have been an exciting period in the history of parkinsonian research. Thanks to the efforts of an extraordinary number of investigators who have entered the field and a close interaction among neurologists, pharmacologists, biochemists, cell biologists, and chemists, we have progressed in a short time span from the first report that MPTP causes neurological symptoms close to those seen in Parkinsonism patients to an understanding of the main events leading to nigrostriatal cell death initiated by MPTP. One purpose of this paper is to summarize the biochemical events involved in this process, emphasizing recent, largely unpublished data and pointing out unresolved questions. Our second aim is to give an overview of what is being done to provide evidence for the hypothesis, which is gaining increasing acceptance, that idiopathic Parkinsonism is caused by slow-acting environmental neurotoxins. We will point out the battery of relatively simple in vitro tests for screening such potential neurotoxins and how they may eventually facilitate elimination of the disease. The original studies to be summarized represent, in part, collaboration with our colleagues, A. Trevor and N. Castagnoli at our University and in part, collaboration with Dr. R. Heikkila’s laboratory.
KeywordsNADH Dehydrogenase Idiopathic Parkinsonism Brain Mitochondrion NADH Oxidation Neurotoxic Action
Unable to display preview. Download preview PDF.
- Salach, J.I., Singer, T.P., Castagnoli, N., Jr. and Trevor, A.J. (1984). Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP. Biochem. Biophys. Res. Commun. 125: 831–825.CrossRefGoogle Scholar
- Javitch, J.A., D’Amato, R.J., Strittmatter, S.M. and Snyder, S.H. (1985). Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. 82: 2173–2177.PubMedCrossRefGoogle Scholar
- Ramsay, R.R. Kowal, A.T., Johnson, M.K., Salach, J.I., and Singer, T.P. (1987). The inhibition site of MPP+, the neurotoxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is near the Q-binding site of NADH dehydrogenase. Arch. Biochim. Biophys. 259: 645–649.CrossRefGoogle Scholar
- Palmer, A., Horgan, D.J., Tisdale, H., Singer, T.P. and Beinert, H. (1968). Studies on the respiratory chain-linked reduced nicotinamide adenine dinucleotide dehydrogenase. XIV. Location of the sites of inhibition of rotenone, barbiturates, and piericidin by means of electron paramagnetic resonance spectroscopy. J. Biol. Chem. 243: 844–847.PubMedGoogle Scholar
- Youngster, S.K., Heikkila, R.E., McKeown, K.A., and Singer, T.P. (to be published)Google Scholar
- Youngster, S.K., (1987). Ph.D. Thesis, New Jersey Medical College.Google Scholar
- Sayre, L.M., Arora, P.K., Feka, S.C., andUrbach, F.L. (1986). Mechanism of induction of Parkinson’s Disease by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Chemical and electrochemical characterization of a geminal-dimethyl-blocked analogue of a postulated toxic metabolite. J. Am. Chem. Soc. 108: 2464–2466.PubMedCrossRefGoogle Scholar
- Christie-Pope, B., Burns, R.S. and Whetsell, W.O., Jr. (1987). Ultrastructural alterations induced by 1-methyl-4-phenylpyridine (MPP +) in organotypic cultures of canine substantia nigra and rat mesencephalon. Neurosci. Soc. Abstr., p.788.Google Scholar
- Sanchez-Ramos, J.R. and Hefti, F., personal communicationGoogle Scholar
- Pressman, B.C. (1963). The effects of guanidine and alkylguanidines on the energy transfer reactions of mitochondria. J. Biol. Chem. 238: 401–409.Google Scholar